Our Blog

Case Study: Clinical Trial Volunteer

Volunteer’s Journey on a Clinical Trial at Re:Cognition Health Geoff’s wife Susie has been a clinical trials volunteer at Re:Cognition Health since 2013. Below he shares their […]

Communication and Dementia

Communication is the Key to Caring for People with Dementia Re:Cognition Health’s Top Tips to Improve Communication   Supporting and caring for somebody with dementia can be […]

How Do You Keep Your Brain Healthy?

Top Tips for Keeping Your Brain Healthy and Strong Our team of Brain and Mind experts are dedicated to paving a way for a future without dementia. […]

Daily Mail Features Clinical Trial Volunteer

Re:Cognition Clinical Trial Volunteer featured in the Daily Mail There have been so many exciting and hugely successful scientific advances in the past decade; including our understanding of Alzheimer’s […]

Addiction

Addiction may be more wide-spread than you think – according to Action on Charity one in three people is addicted to something. We commonly think of alcohol […]

Dementia Care at Christmas

Dementia Care at Christmas Caring for your relative or friend with dementia can be a challenging time for everyone at Christmas. The change in routine, new environment, […]

Re:Cognition Health Wins Award

Re:Cognition Health Honoured for Positive Impact in Growing Business Awards   We are absolutely delighted to announce that Re:Cognition Health won The Bridges Positive Impact award at […]

Obsessive Compulsive Disorder

OBSESSIVE COMPULSIVE DISORDER A serious mental health concern   Dr Dimitrios Paschos, Consultant Psychiatrist at Re:Cognition Health was interviewed by Yahoo! News about Obsessive Compulsive Disorder (OCD). […]

New Migraine Treatment Approved

Migraine Treatment Receives FDA Approval in the USA Drug currently undergoing UK clinical trial at Re:Cognition Health REYVOW (lasmiditan) is a migraine medication which is currently undergoing […]

First treatment to slow Alzheimer’s progression

Re:Cognition Health proud to be part of ground-breaking clinical trial   Dr Emer MacSweeney, CEO at Re:Cognition Health shares her excitement about the potential success of Aducanumab, […]